Coxanto Capsule
Product Images NDC 70512-814

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Coxanto (NDC 70512-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemicalstructure)

Chemical structure diagram of oxaprozin, the active ingredient in COXANTO 300 mg capsules, showing its molecular arrangement with phenyl groups and a carboxylic acid functional group.*

FDA Label Image

Label (Label)

COXANTO Oxaprozin Capsules 300 mg oral capsule label by SOLA Pharmaceuticals, LLC. The label includes storage instructions, dosage note referencing prescribing information, quantity of 60 capsules, and barcode. Manufactured by SOLA Pharmaceuticals in Baton Rouge, LA.*

FDA Label Image

Sola Logo (Solalogo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.